Filed by 17 state attorneys general, the lawsuit targets trans people by undermining a core pillar of disability rights.
The U.S. FDA has officially declared that Novo Nordisk’s (NVO) popular diabetes and weight loss therapies, Ozempic and Wegovy, are no longer in ...
CAPLYTA net product sales grew to $199.2 million, representing a 51%increase over the same period in 2023Full year 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback